(1 H, d, J = 8.0 Hz), 6.79 (1 H, d, J = 8.0 Hz), 5.90 (1 H, dddd,
J = 17.0, 10.0, 7.0, 7.0 Hz), 5.58–5.52 (1 H, m), 5.14 (1 H, dd,
J = 17.0, 1.0 Hz), 5.07 (1 H, dt, J = 10.0, 1.0 Hz), 4.33–5.28
(1 H, m), 4.18–4.13 (1 H, m), 3.93–3.88 (1 H, m), 3.46 (1 H, dd,
J = 15.0, 10.5 Hz), 2.44 (1 H, J = 15.0, 1.5 Hz), 2.48–2.35 (2 H,
m), 1.92 (1 H, ddd, J = 13.5, 5.0, 5.0 Hz), 1.81 (1 H, dt, J = 14.5,
10.5 Hz), 1.65–1.58 (1 H, m), 1.60 (1 H, dt, J = 14.5, 2.0 Hz),
1.56–1.47 (2 H, m), 0.99 (9 H, s), 0.92 (9 H, s), 0.26 (3 H, s), 0.20
(3 H, s), 0.10 (3 H, s), 0.09 (3 H, s); δC (125 MHz, acetone-d6):
169.54, 152.45, 140.94, 134.98, 130.17, 129.85, 124.08, 117.98,
117.67, 74.20, 73.75, 66.75, 66.55, 40.22, 40.10, 39.97, 39.47,
38.87, 26.25, 26.16, 18.88, 18.55, Ϫ3.79, Ϫ4.22, Ϫ4.61, Ϫ4.64.
Found (CI): 547.3275 [MH]ϩ, C30H50O5Si2 requires 547.3275
(0.0 ppm error); m/z (CI) 564 (12%, [MNH4]ϩ), 547 (85,
[MH]ϩ), 529 (100), 489 (14), 428 (30), 261 (25), 137 (30).
After 15 min the reaction mixture had darkened considerably.
Sat. NH4Cl(aq) (0.1 mL) was then added, the mixture stirred at
Ϫ10 ЊC for a further 10 min, then the solvent evaporated under
reduced pressure. Flash chromatography (petroleum ether:
EtOAc, 3 : 1 to 1 : 1) gave first recovered starting material 52
(2 mg, 20%), then the title compound 54 (2 mg, 20%) as a yellow-
ish oil, which was recrystallised from ether to give a yellowish
solid; Rf 0.27 (petroleum ether : EtOAc, 1 : 1); mp 123–124 ЊC;
[α]D Ϫ110 (c 0.20, MeOH); νmax/cmϪ1 (thin deposit): 3448, 2941,
1707, 1644, 1575, 1467, 1268, 1110; δH (500 MHz, acetone-d6):
7.37 (1 H, t, J = 8.0 Hz), 7.01 (1 H, d, J = 8.0 Hz), 6.86 (1 H, d,
J = 8.0 Hz), 6.71 (1 H, d, J = 16.0 Hz), 6.00 (1 H, ddd, J = 16.0,
8.0, 6.5 Hz), 5.87 (1 H, dddd, J = 16.0, 10.0, 6.5, 6.5 Hz),
5.31 (1 H, m), 5.11 (1 H, dq, J = 17.0, 1.5 Hz), 5.08 (1 H, ddt,
J = 10.0, 2.5, 1.0 Hz), 4.46 (1 H, m), 3.81 (1 H, d, J = 6.0 Hz),
3.23 (2 H, m), 2.99 (1 H, dd, J = 13.5, 3.5 Hz), 2.43 (2 H, tq,
J = 6.0, 1.5 Hz), 2.26 (1 H, dd, J = 13.5, 9.5 Hz), 1.99 (1 H, ddd,
J = 14.0, 11.0, 5.0 Hz), 1.76 (1 H, ddd, J = 14.0, 9.5, 3.5 Hz);
δC (125 MHz, acetone-d6): 206.75, 167.87, 157.29, 136.96,
134.60, 134.04, 131.06, 128.85, 124.16, 121.23, 118.05, 111.13,
71.78, 65.21, 56.33, 50.15, 47.93, 41.77, 40.36. Found (CI):
348.1812 [MNH4]ϩ, C19H22O5 requires 348.1811 (0.2 ppm
error); m/z (CI) 348 (10%, [MNH4]ϩ), 331 (100, [MH]ϩ), 313
(85), 295 (15), 234 (15), 217 (35), 174 (20), 148 (15).
(1R,11R,13R)-11-Allyl-7-methoxy-10,17-dioxatricyclo-
[11.3.1.03,8]heptadeca-3,5,7-triene-9,15-dione (52)
(a) To a solution of lactone 49 (50 mg, 0.11 mmol) in THF
(2 mL) was added TBAF (1 M in THF, 0.22 mL, 0.22 mmol)
with stirring at rt. After 5 h the solvent was evaporated under
reduced pressure and the residue purified by flash chromato-
graphy (petroleum ether : EtOAc, 4 : 1 to EtOAc) to give
(1R,11R,13R,15S)-11-allyl-15-hydroxy-7-methoxy-10,17-di-
oxatricyclo[11.3.1.03,8]heptadeca-3,5,7-trien-9-one (36 mg,
97%) as a colourless oil; Rf 0.50 (EtOAc); [α]D Ϫ10.6 (c 1.50,
CHCl3); νmax/cmϪ1 (thin film) 3460, 2946, 2923, 2841, 1732,
1598, 1581, 1470, 1272, 1119, 1089, 1071; δH (270 MHz,
CDCl3): 7.21 (1 H, t, J = 8.0 Hz), 6.77 (1 H, d, J = 8.0 Hz), 6.72
(1 H, d, J = 8.0 Hz), 5.86 (1 H, dddd, J = 17.0, 10.0, 7.0, 7.0 Hz),
5.62–5.52 (1 H, m), 5.18–5.08 (2 H, m), 4.34–4.25 (1 H, m),
4.05–3.93 (2 H, m, 9-H), 3.77 (3 H, s), 3.37 (1 H, dd, J = 15.0,
10.0 Hz), 2.50–2.27 (2 H, m), 2.44 (1 H, d, J = 14.5 Hz), 2.08
(1 H, broad s), 2.00–182 (2 H, m), 1.77–1.70 (1 H, dt, J = 13.0,
6.0 Hz), 1.58–1.46 (3 H, m); δC (67.9 MHz, CDCl3): 169.2,
156.1, 138.5, 133.7, 130.0, 125.5, 122.9, 117.8, 109.5, 73.0, 72.7,
67.6, 65.1, 55.9, 39.7, 39.5, 38.9, 38.7, 38.2. Found (CI):
333.1701 [MH]ϩ, C19H24O5 requires 333.1702 (0.4 ppm error);
m/z (CI) 350 (10%, [MNH4]ϩ), 333 (100, [MH]ϩ), 315 (63), 245
(10), 148 (25).
Acknowledgements
We thank the BBSRC and GlaxoSmithKline for a CASE
studentship (I. S.) and Elsevier Science for additional financial
support (A. L. and S. A. S.).
References
1 (a) R. Jansen, B. Kunze, F. Sasse, H. Reichenbach and
G. Höfle, Drugs from Natural Products Conference, Dublin, 1998;
(b) B. Kunze, R. Jansen, F. Sasse, G. Höfle and H. Reichenbach,
J. Antibiotics, 1998, 51, 1075–1080; (c) R. Jansen, B. Kunze,
H. Reichenbach and G. Höfle, Eur. J. Org. Chem., 2000, 913–919.
The absolute stereochemistry of (Ϫ)-apicularen A in the original
publication (ref. 1a) was subsequently revised to the enantiomeric
form (ref. 1c).
2 F. Sasse, personal communication, referred to in ref. 1c.
(b) To a solution of the alcohol from (a) (30 mg, 0.090 mmol)
in dichloromethane (2 mL) was added Dess–Martin period-
inane (42 mg, 0.099 mmol) with stirring under N2 at rt. After 1 h
the solvent was evaporated under reduced pressure and the
residue purified by flash chromatography (petroleum ether :
EtOAc, 1 : 1) to give the title compound 52 (29 mg, 97%) as a
white crystalline solid; Rf 0.40 (EtOAc); mp 184–185 ЊC; [α]D
Ϫ140 (c 0.60, CHCl3); νmax/cmϪ1 (thin deposit) 2934, 2908,
1709, 1598, 1470, 1355, 1278, 1254, 1116, 1071; δH (270 MHz,
CDCl3): 7.28 (1 H, t, J = 8.0 Hz), 6.84 (1 H, d, J = 8.0 Hz), 6.79
(1 H, d, J = 8.0 Hz), 5.88 (1 H, dddd, J = 17.0, 10.0, 7.0, 7.0 Hz),
5.68–5.58 (1 H, m), 5.17 (1 H, ddd, J = 17.0, 3.0, 1.5 Hz), 5.17–
5.12 (1 H, m), 4.50 (1 H, tddd, J = 10.0, 3.5, 1.5, 0.5), 4.25 (1 H,
dddd, J = 11.0, 8.5, 6.5, 2.0), 3.81 (3 H, s), 3.46 (1 H, dd,
J = 14.0, 11.0 Hz), 2.67 (1 H, ddd, J = 15.5, 6.5, 0.5 Hz), 2.52
(1 H, dd, J = 15.5, 8.5 Hz), 2.51–2.31 (4 H, m), 2.22 (1 H, dd,
J = 17.0, 10.0 Hz), 1.85 (1 H, ddd, J = 15.0, 11.0, 10.0 Hz), 1.71
(1 H, ddd, J = 15.0, 3.5, 1.5 Hz); δC (67.9 MHz, CDCl3): 207.2,
169.9, 156.1, 137.1, 133.5, 130.6, 125.8, 122.7, 118.1, 110.2,
74.2, 72.2, 68.3, 55.9, 47.2, 45.2, 40.2, 39.1, 39.0. Found (CI):
331.1546 [MH]ϩ, C19H22O5 requires 331.1545 (0.2 ppm error);
m/z (CI) 348 (11%, [MNH4]ϩ), 331 (100, [MH]ϩ), 313 (63), 177
(12), 148 (24).
3 (a) K. L. Erickson, J. A. Beutler, J. H. Cardellina II and M. R. Boyd,
J. Org. Chem., 1997, 62, 8188–8192; K. L. Erickson, J. A. Beutler,
J. H. Cardellina II and M. R. Boyd, J. Org. Chem., 2001, 66, 1532;
(b) T. C. McKee, D. L. Galinis, L. K. Pannell, J. H. Cardellina II,
J. Lakkso, C. M. Ireland, L. Murray, R. J. Capon and M. R. Boyd,
J. Org. Chem., 1998, 63, 7805–7810; (c) K. A. Dekker, R. J. Aiello,
H. Hirai, T. Inagaki, T. Sakakibara, Y. Suzuki, J. F. Thompson,
Y. Yamaguchi and N. Kojima, J. Antibiot., 1998, 51, 14–20;
(d ) J. W. Kim, K. Shin-ya, K. Furihata, Y. Hayakawa and H. Seto,
J. Org. Chem., 1999, 64, 153–155.
4 M. R. Boyd, C. Farina, P. Belfiore, S. Gagliardi, J. W. Kim,
Y. Hayakawa, J. A. Beutler, T. C. McKee, B. J. Bowman and
E. J. Bowman, J. Pharmacol. Exp. Ther., 2001, 297, 114–120.
5 (a) A. Fürstner, G. Seidel and N. Kindler, Tetrahedron, 1999, 55,
8215–8230; (b) A. Fürstner, O. R. Thiel and G. Blanda, Org. Lett.,
2000, 2, 3731–3734; (c) Y. Wu, O. R. Seguil and J. K. De Brabander,
Org. Lett., 2000, 2, 4241–4244; (d ) A. Bhattacharjee and J. K.
De Brabander, Tetrahedron Lett., 2000, 41, 8069–8073; (e) J. T.
Feutrill, G. A. Holloway, F. Hilli, H. M. Hügel and M. A. Rizzacasa,
Tetrahedron Lett., 2000, 41, 8569–8572; ( f ) B. B. Snider and
F. Song, Org. Lett., 2000, 2, 407–408; (g) I. Stefanuti, S. A.
Smith and R. J. K. Taylor, Tetrahedron Lett., 2000, 41, 3735–3738;
(h) S. A. Raw and R. J. K. Taylor, Tetrahedron Lett., 2000, 41,
10357–10361; (i) K. Kuramochi, H. Watanabe and T. Kitahara,
Synlett, 2000, 397–399; (j) R. Shen and J. A. Porco Jr, Org. Lett.,
2000, 2, 1333–1336; (k) Y. Wu, L. Esser and J. K. De Brabander,
Angew. Chem., Int. Ed., 2000, 39, 4308–4310; (l ) G. L. Georg,
Y. M. Ahn, B. Blackman, F. Farokhi, P. T. Flaherty, C. J.
Mossman, S. Roy and K. Yang, Chem. Commun., 2001, 255–
256; (m) F. Scheufler and M. E. Maier, Synlett, 2001, 1221–1224;
(n) R. S. Coleman and R. Garg, Org. Lett., 2001, 3, 3487–3490;
(o) A. Fürstner, C. Brehm and Y. Cancho-Grande, Org. Lett., 2001,
3, 3955–3957; (p) S. M. Kühnert and M. E. Maier, Org. Lett., 2002,
4, 643–646; (q) M. Bauer and M. E. Maier, Org. Lett., 2002, 4, 2205–
(3R,5R)-3-Allyl-5-hydroxy-14-methoxy-3,4,5,6-tetrahydro-1H-
2-oxabenzocyclododecene-1,7(8H)-dione (54)
To a freshly prepared stirred solution of LDA (0.1 M in THF,
3.0 mL, 0.30 mmol) was added a solution of pyranone 52
(10 mg, 0.030 mmol) in THF (0.6 mL) under N2 at Ϫ10 ЊC.
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 1 0 4 – 1 1 6
115